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PINTing for p53
Ramin ShiekhattarAbstract
A new study identifies the long noncoding RNA Pint
as a regulator of cellular proliferation and a target of
the p53 pathway.derstanding the direct targets of p53 transcriptionalIntroduction: the new revolution in genomics
Analysis of the massive quantity of data generated by
next-generation sequencing has given us a new appreci-
ation of the complexity of the transcriptome, and has also
shed light on the more than 90% of the genome that was
previously thought not to have critical functions. Among
these findings is the realization that a large number of
noncoding RNAs map to extra- and intragenic regulatory
elements known as enhancers, and that the expression of
such noncoding transcripts has important functional con-
sequences in transcriptional regulation [1-4]. However,
non-enhancer classes of long intergenic non-coding RNAs
(lincRNAs) may fulfill other functions in the nucleus
or the cytoplasm. These transcripts are predominantly
polyadenylated and processed by the splicing machin-
ery. Importantly, many of these lincRNAs are targeted
by specific transcription factors responding to critical
cellular signaling pathways.
The prevailing theory regarding the mechanism of
action of many nuclear lincRNAs stipulates their asso-
ciation with chromatin regulatory complexes, providing
additional binding energy for their targeting to specific
genomic loci; indeed, a number of lincRNAs have recently
been shown to exhibit chromatin-binding behavior as a
mechanism of gene regulation. In this issue of Genome
Biology, Marín-Béjar et al. [5] identify a lincRNA termed
tumor protein 53 (p53)-induced noncoding transcript
(Pint) that associates with Polycomb repressive complex 2
(PRC2) and regulates transcription.Correspondence: shiekhattar@wistar.org
The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA
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p53 has been heralded as the gatekeeper of the genome
in human cancers, owing to the large number of tumors
that display mutations in this transcription factor. A
significant effort has therefore been directed toward un-
regulation and elucidating the cellular pathways that
such p53 targets control. Recent studies have uncovered
long noncoding RNAs as novel targets of p53 tumor
suppression [6,7]. Marín-Béjar et al. used custom tiling
microarrays in a mouse model system to identify lincRNAs
that are regulated by p53. This analysis resulted in the
identification of Pint, a lincRNA with multiple isoforms.
Subsequent experiments focused on the longest Pint
isoform containing four exons, which displayed a high
level of expression in most tissues examined. Analysis of
the genomic locus of Pint revealed three p53 binding
sites: a promoter-proximal binding site and two distal
binding sites a few hundred thousand base pairs from
the transcriptional start site. Functional analysis revealed
that p53 binds to these regulatory sites and mediates the
activation of Pint following induction of p53.Mouse Pint promotes growth
To assess Pint functions, Marin-Bejar et al. depleted
Pint levels using antisense oligos, and measured cellular
growth before and after induction of DNA damage. Pint
depletion led to decreased cellular proliferation, which
was more prominent following DNA damage induction.
Remarkably, overexpression of Pint led to an increase in
cellular growth, strongly suggesting a trans-mediated
mechanism of action for Pint in controlling proliferation.
An analysis of the consequences of Pint depletion, on
the other hand, demonstrated that lowering Pint con-
centration causes an increase in apoptosis and a de-
crease in the fraction of cells in the S-phase of the cell
cycle. As expected, overexpression of Pint had opposite
effects on apoptosis and cell cycle progression. Import-
antly, manipulation of Pint levels had similar effects in
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ism of action for regulation of cellular growth.
To gain further insight into the mechanism by which
Pint regulates proliferation, Marín-Béjar et al. depleted
Pint levels following the induction of DNA damage and
analyzed gene expression changes using a microarray
platform. Consistent with the role of mouse Pint in the
regulation of proliferation, gene expression changes in
pathways regulating cellular growth and survival were un-
covered, including TGF-β and MAPK pathways. Changes
in gene expression were also observed in transcripts regu-
lated by the p53 pathway. Indeed, depletion of p53 resulted
in changes in gene expression that partially overlapped that
of Pint depletion. Marín-Béjar et al. surmised that such
gene expression changes are mediated in trans, given that
the neighboring genes did not display changes in their
expression following depletion of Pint, although the gene
expression changes following overexpression of Pint were
not analyzed.
It would be informative to know whether Pint over-
expression induces opposing changes in gene expression
to those seen following its depletion. Such overexpression
experiments would also allow for detailed structure/
function analysis of Pint with regard to gene expression
and cellular proliferation.PINT binds PRC2 and influences its chromatin
residence at a subset of genes
To gain insight into the molecular basis of Pint tran-
scriptional regulatory function, Marín-Béjar et al. exam-
ined its association with PRC2. The current model for
the targeting of PRC2 implicates noncoding RNAs in the
recruitment of this complex to its genomic sites [8-10].
Pint was found to be highly enriched in the nucleus and
to associate directly with the PRC2 complex. Moreover, de-
pletion of Pint resulted in decreased chromatin residence
of PRC2 at a subset of Pint-regulated genes displaying his-
tone H3 lysine 27 methylation, a mark of transcriptional
repression.
To mechanistically link the PRC2 complex and changes
in cellular proliferation by altering Pint levels, Marín-Béjar
et al. examined the consequences of Pint manipulation in
3T3 cells in which the Ezh2 subunit of PRC2 was depleted.
Whereas overexpression of Pint in control cells promoted
growth, increased expression of Pint in the absence of
PRC2 did not significantly affect cellular proliferation.
These results point to a critical role for PRC2 in mediating
the growth regulatory function of Pint. It is important to
note that although Pint may cooperate with PRC2 at a
subset of its targets, it is likely that other chromatin regu-
lators may also associate with Pint and its scope of inter-
action with chromatin regulatory complexes may be much
larger than PRC2 alone.Human PINT displays tumor suppressive function
Having established functional and molecular characteris-
tics of Pint in a mouse model, Marín-Béjar et al. turned
their attention to the analysis of a possible homolog of
Pint in human cells (PINT), initially identified on the
basis of synteny with the mouse genome. It has often
been difficult to discern the evolutionary conservation of
lincRNAs, given that the evolutionary pressures maintained
through codon usage in protein-coding genes are not
present. However, in most cases the overall genomic pos-
ition and short stretches of sequence conservation are
preserved among close mammalian species. Indeed, small
patches of PINT 5′-end sequences have homology with the
mouse Pint. Moreover, similar to mouse Pint, human PINT
is regulated by p53 through proximal and distal genomic
binding sites.
But the functional conservation between human PINT
and mouse Pint turned out to be only at a superficial level.
Surprisingly, human PINT overexpression suppressed cel-
lular proliferation, an opposite effect to that seen with
mouse Pint. Indeed, analysis of a panel of human colorec-
tal tumors revealed a significant downregulation in PINT,
consistent with a role in tumor suppression. Therefore, it
is tempting to speculate that PINT may function as a crit-
ical target of p53 in cancer cells and may contribute to the
tumor suppressive function of p53 in human cancers.Concluding remarks
We are at the very early stages of our functional under-
standing of lincRNAs and noncoding RNAs in general.
There is much to learn about the biogenesis pathway of
lincRNAs and their mechanism of action. Clearly, the
current work on Pint has begun to shed light on the bio-
logical function of lincRNAs in cellular proliferation and
DNA damage response through the p53 protein, in this
case, intriguingly, as a mediator of p53 autoregulation.
The next steps will entail the genetic dissection of Pint
in model organisms and a greater insight into the se-
quence or structural requirements in Pint that govern
interactions with PRC2 and other chromatin regulatory
complexes. These are high times for the study of long
noncoding RNAs as the new players in town regulating
mammalian gene expression.Abbreviations
Ezh2: Enhancer of zeste homolog 2; lincRNA: Long intergenic non-coding
RNA; MAPK: Mitogen-activated protein kinase; p53: Tumor protein 53;
Pint: p53-induced transcript; PRC2: Polycomb repressive complex 2;
TGF: Transforming growth factor.30
Competing interests
The author declares that he has no competing interests.
Published: September 2013




1. De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, Muller H,
Ragoussis J, Wei CL, Natoli G: A large fraction of extragenic RNA PolII
transcription sites overlap enhancers. PLOS Biol 2010, 8:e1000384.
2. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA,
Laptewicz M, Barbara-Haley K, Kuersten S, Markenscoff-Papadimitriou E, Kuhl
D, Bito H, Worley PF, Kreiman G, Greenberg ME: Widespread transcription
at neuronal activity-regulated enhancers. Nature 2010, 465:182–187.
3. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F,
Zytnicki M, Notredame C, Huang Q, Guigo R, Shiekhattar R: Long
noncoding RNAs with enhancer-like function in human cells. Cell 2010,
143:46–58.
4. Melo CA, Drost J, Wijchers PJ, van de Werken H, de Wit E, Oude Vrielink JA,
Elkon R, Melo SA, Léveillé N, Kalluri R, de Laat W, Agami R: eRNAs are
required for p53-dependent enhancer activity and gene transcription.
Mol Cell 2013, 49:524–535.
5. Marín-Béjar O, Marchese FP, Athie A, Sánchez Y, González J, Segura V,
Huang L, Moreno I, Navarro A, Monzó M, García-Foncillas J, Rinn JL, Guo S,
Huarte M: PINT lincRNA connects the p53 pathway with epigenetic
silencing by the Polycomb repressive complex 2. Genome Biol 2013, 14:
6. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D,
Khalil AM, Zuk O, Amit I, Rbani M, Attardi LD, Regev A, Lander ES, Jacks T,
Rinn JL: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell 2010, 142:409–419.
7. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, Wu F, Mo YY: LncRNA
loc285194 is a p53-regulated suppressor. Nucleic Acids Res 2013,
41:4976–4987.
8. Rinn JL, Kertesz M, Wang JK, Sqazzo SL, Xu X, Brugmann SA, Goodnough
LH, Helms JA, Farnham PJ, Segal E, Chang HY: Functional demarcation of
active and silent chromatin domains in human HOX loci by noncoding
RNAs. Cell 2007, 129:1311–1323.
9. Rinn JL, Chang HY: Genome regulation by long nocoding RNAs. Annu Rev
Biochem 2012, 81:145–166.
10. Kaneko S, Li G, Son J, Xu CF, Margueron R, Neubert TA, Reinberg D:
Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated
and up-regulates its binding to ncRNA. Gene Dev 2010, 24:2615–2620.
Cite this article as: Shiekhattar: PINTing for p53. Genome Biology
2013 14:132.
